These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16956436)

  • 1. Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever.
    Sakallioglu O; Duzova A; Ozen S
    Clin Exp Rheumatol; 2006; 24(4):435-7. PubMed ID: 16956436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sacroileitis and pericarditis: atypical presentation of tumor necrosis factor receptor-associated periodic syndrome and response to etanercept therapy.
    Cantarini L; Lucherini OM; Cimaz R; Baldari CT; Laghi Pasini F; Galeazzi M
    Clin Exp Rheumatol; 2010; 28(2):290-1. PubMed ID: 20483057
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
    Bilgen SA; Kilic L; Akdogan A; Kiraz S; Kalyoncu U; Karadag O; Ertenli I; Dogan I; Calguneri M
    J Clin Rheumatol; 2011 Oct; 17(7):358-62. PubMed ID: 21946459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.
    Ozen S; Bilginer Y; Aktay Ayaz N; Calguneri M
    J Rheumatol; 2011 Mar; 38(3):516-8. PubMed ID: 21159830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF.
    Erten S; Erten SF; Altunoglu A
    Rheumatol Int; 2012 Apr; 32(4):1095-7. PubMed ID: 21431291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents.
    Seyahi E; Ozdogan H; Celik S; Ugurlu S; Yazici H
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S99-103. PubMed ID: 17067437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Mediterranean fever successfully treated with etanercept.
    Mor A; Pillinger MH; Kishimoto M; Abeles AM; Livneh A
    J Clin Rheumatol; 2007 Feb; 13(1):38-40. PubMed ID: 17278949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study.
    Schmeling H; Mathony K; John V; Keysser G; Burdach S; Horneff G
    Ann Rheum Dis; 2001 Apr; 60(4):410-2. PubMed ID: 11247875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The medical odyssey of a boy with arthritis of familial Mediterranean fever.
    Conca W; Ghatasheh G; Al-Salam S; Neidl Van Gorkom K
    Int J Rheum Dis; 2012 Apr; 15(2):e37-9. PubMed ID: 22462434
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial.
    ter Wee MM; den Uyl D; Boers M; Kerstens P; Nurmohamed M; van Schaardenburg D; Voskuyl AE; Lems WF
    Ann Rheum Dis; 2015 Jun; 74(6):1233-40. PubMed ID: 24818633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of familial Mediterranean fever and juvenile idiopathic arthritis with osteoporosis successfully treated with etanercept.
    Kaya S; Kaptanoglu E; Elden H; Hizmetli S
    Intern Med; 2010; 49(6):619-22. PubMed ID: 20228604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
    van der Heijde D; Klareskog L; Landewé R; Bruyn GA; Cantagrel A; Durez P; Herrero-Beaumont G; Molad Y; Codreanu C; Valentini G; Zahora R; Pedersen R; MacPeek D; Wajdula J; Fatenejad S
    Arthritis Rheum; 2007 Dec; 56(12):3928-39. PubMed ID: 18050208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
    Nerome Y; Imanaka H; Nonaka Y; Takei S
    Mod Rheumatol; 2007; 17(6):526-8. PubMed ID: 18084710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
    Klareskog L; van der Heijde D; de Jager JP; Gough A; Kalden J; Malaise M; Martín Mola E; Pavelka K; Sany J; Settas L; Wajdula J; Pedersen R; Fatenejad S; Sanda M;
    Lancet; 2004 Feb; 363(9410):675-81. PubMed ID: 15001324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with infliximab of a patient with tumor necrosis factor-associated periodic syndrome (TRAPS) who failed to respond to etanercept.
    Krelenbaum M; Chaiton A
    J Rheumatol; 2010 Aug; 37(8):1780-2. PubMed ID: 20675856
    [No Abstract]   [Full Text] [Related]  

  • 17. Etanercept in systemic juvenile idiopathic arthritis.
    Russo RA; Katsicas MM; Zelazko M
    Clin Exp Rheumatol; 2002; 20(5):723-6. PubMed ID: 12412209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population.
    Iwamoto N; Kawakami A; Fujikawa K; Aramaki T; Kawashiri SY; Tamai M; Arima K; Ichinose K; Kamachi M; Yamasaki S; Nakamura H; Nakashima M; Mizokami A; Goto A; Fukuda T; Matsuoka N; Ueki Y; Tsukada T; Migita K; Shoumura F; Kawabe Y; Shibatomi K; Mine M; Ida H; Origuchi T; Aoyagi K; Eguchi K
    Mod Rheumatol; 2009; 19(5):488-92. PubMed ID: 19578932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etanercept improved primary biliary cirrhosis associated with rheumatoid arthritis.
    Ogata A; Terabe F; Nakanishi K; Kawai M; Kuwahara Y; Hirano T; Arimitsu J; Hagihara K; Shima Y; Narazaki M; Tanaka T; Kawase I
    Joint Bone Spine; 2009 Jan; 76(1):105-7. PubMed ID: 18848488
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to letter by Yazici and Yazici commenting on the two-year report on the trial of etanercept and methotrexate with radiographic and patient outcomes.
    van der Heijde D; Klareskog L
    Arthritis Rheum; 2007 Mar; 56(3):1031-2. PubMed ID: 17328083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.